Lornbloc 4 mg, 8 mg FC tablets
PDF Leaflet Revision Date: 27 February 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Short term treatment of mild to moderate pain and inflammation.
Dosage (summary)
Adults: 8-16 mg/day in 2-3 doses; max 16 mg/day.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Anticoagulants
- Methotrexate
- Lithium
- Diuretics
- ACE inhibitors
Contraindications
- Hypersensitivity to lornoxicam
- Gastrointestinal bleeding
- Severe renal impairment
- Severe liver impairment
- Pregnancy
- Lactation
Common side effects
- Nausea
- Dyspepsia
- Abdominal pain
- Diarrhoea
- Vomiting
Counselling Points
- Take with sufficient liquid before meals
- Report unusual abdominal symptoms
- Avoid use in pregnancy and breastfeeding
Serious warnings
- Serious skin reactions
- Gastrointestinal ulceration
- Increased risk of cardiovascular events
Important Disclaimer
The Lornbloc 4 mg, 8 mg FC tablets professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
